Möchten Sie immer auf dem neuesten Stand bleiben?

FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimodCompany unveils NEPTUNE...

Xeltis announces that it has exceeded 50% enrollment in its US pivotal trial for aXess™

Vecna Robotics today announced CaseFlow™ Voice, the only case picking automation solution with fully integrated voice technology.

~ Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared to a propensity score-matched external...

Pivotal, the leader in light electric Vertical Takeoff and Landing (eVTOL) aircraft, has achieved 1,117 crewed flights in its BlackFly, a category first

Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback ...

FDA removes clinical hold; Company may proceed with VIITAL™ study Company expects to initiate study in the first quarter of 2020 Primary endpoint confirmed as proportion of wounds with greater than...

NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of SRC Energy Inc. (NYSE:...

         Atos permet une adoption plus rapide du cloud avec les nouveaux accélérateurs SyntBots pour la Plateforme Pivotal Paris, France - le 9 octobre 2019 – Atos, leader international de la...

         Atos Delivers Faster Cloud Adoption with New SyntBots Accelerators for Pivotal Platform Paris, France - October 9, 2019 – Atos, a global leader in digital transformation, today announced...